These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 27144463)
1. Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy. Lee Y; Kim H; Kang S; Lee J; Park J; Jon S Angew Chem Int Ed Engl; 2016 Jun; 55(26):7460-3. PubMed ID: 27144463 [TBL] [Abstract][Full Text] [Related]
2. Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma. Kim DE; Lee Y; Kim M; Lee S; Jon S; Lee SH Biomaterials; 2017 Sep; 140():37-44. PubMed ID: 28624706 [TBL] [Abstract][Full Text] [Related]
3. PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation. Kim MJ; Lee Y; Jon S; Lee DY Biomaterials; 2017 Jul; 133():242-252. PubMed ID: 28448818 [TBL] [Abstract][Full Text] [Related]
4. Bilirubin Nanomedicine Rescues Intestinal Barrier Destruction and Restores Mucosal Immunity in Colitis. Rahman AT; Shin J; Whang CH; Jung W; Yoo D; Seo C; Cho BK; Jon S ACS Nano; 2023 Jun; 17(11):10996-11013. PubMed ID: 37227087 [TBL] [Abstract][Full Text] [Related]
5. Black Pigment Gallstone Inspired Platinum-Chelated Bilirubin Nanoparticles for Combined Photoacoustic Imaging and Photothermal Therapy of Cancers. Lee DY; Kim JY; Lee Y; Lee S; Miao W; Kim HS; Min JJ; Jon S Angew Chem Int Ed Engl; 2017 Oct; 56(44):13684-13688. PubMed ID: 28869355 [TBL] [Abstract][Full Text] [Related]
6. Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling. Keum H; Kim TW; Kim Y; Seo C; Son Y; Kim J; Kim D; Jung W; Whang CH; Jon S J Control Release; 2020 Sep; 325():359-369. PubMed ID: 32681946 [TBL] [Abstract][Full Text] [Related]
7. Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury. Kim JY; Lee DY; Kang S; Miao W; Kim H; Lee Y; Jon S Biomaterials; 2017 Jul; 133():1-10. PubMed ID: 28414974 [TBL] [Abstract][Full Text] [Related]
8. Oral Delivery of Transformable Bilirubin Self-Assembled System for Targeted Therapy of Colitis. Chen Z; Chen Y; Hao W; Shui M; Zhang J; Zhou H; Zhang C; Wang Y; Wang S Adv Healthc Mater; 2023 Oct; 12(26):e2300946. PubMed ID: 37317667 [TBL] [Abstract][Full Text] [Related]
9. Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells. Kim TW; Kim Y; Jung W; Kim DE; Keum H; Son Y; Jon S J Control Release; 2021 Mar; 331():74-84. PubMed ID: 33450316 [TBL] [Abstract][Full Text] [Related]
10. Bilirubin Nanoparticles Protect Against Cardiac Ischemia/Reperfusion Injury in Mice. Ai W; Bae S; Ke Q; Su S; Li R; Chen Y; Yoo D; Lee E; Jon S; Kang PM J Am Heart Assoc; 2021 Oct; 10(20):e021212. PubMed ID: 34622671 [TBL] [Abstract][Full Text] [Related]
11. A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis. Keum H; Kim D; Kim J; Kim TW; Whang CH; Jung W; Jon S Biomaterials; 2021 Aug; 275():120986. PubMed ID: 34175563 [TBL] [Abstract][Full Text] [Related]
13. Delivery of tacrolimus with cationic lipid-assisted nanoparticles for ulcerative colitis therapy. Wang JL; Gan YJ; Iqbal S; Jiang W; Yuan YY; Wang J Biomater Sci; 2018 Jun; 6(7):1916-1922. PubMed ID: 29850666 [TBL] [Abstract][Full Text] [Related]
14. Can bilirubin nanomedicine become a hope for the management of COVID-19? Khurana I; Allawadhi P; Khurana A; Srivastava AK; Navik U; Banothu AK; Bharani KK Med Hypotheses; 2021 Apr; 149():110534. PubMed ID: 33640714 [TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Effects of PEGylated Human Adrenomedullin in a Mouse DSS-Induced Colitis Model. Nagata S; Yamasaki M; Kitamura K Drug Dev Res; 2017 Jun; 78(3-4):129-134. PubMed ID: 28449192 [TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight polyethylene glycol improves survival in experimental sepsis. Ackland GL; Gutierrez Del Arroyo A; Yao ST; Stephens RC; Dyson A; Klein NJ; Singer M; Gourine AV Crit Care Med; 2010 Feb; 38(2):629-36. PubMed ID: 20009757 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory Glycocalyx-Mimicking Nanoparticles for Colitis Treatment: Construction and In Vivo Evaluation. Yoo D; Whang CH; Hong J; Kim D; Prayogo MC; Son Y; Jung W; Lee S; Lee HS; Jon S Angew Chem Int Ed Engl; 2023 Aug; 62(34):e202304815. PubMed ID: 37310766 [TBL] [Abstract][Full Text] [Related]
18. Ultrasmall Rhodium Nanozyme with RONS Scavenging and Photothermal Activities for Anti-Inflammation and Antitumor Theranostics of Colon Diseases. Miao Z; Jiang S; Ding M; Sun S; Ma Y; Younis MR; He G; Wang J; Lin J; Cao Z; Huang P; Zha Z Nano Lett; 2020 May; 20(5):3079-3089. PubMed ID: 32348149 [TBL] [Abstract][Full Text] [Related]
19. Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy. Vong LB; Mo J; Abrahamsson B; Nagasaki Y J Control Release; 2015 Jul; 210():19-25. PubMed ID: 25998050 [TBL] [Abstract][Full Text] [Related]
20. Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles. Hsieh YC; Cheng TC; Wang HE; Li JJ; Lin WW; Huang CC; Chuang CH; Wang YT; Wang JY; Roffler SR; Chuang KH; Cheng TL Sci Rep; 2016 Dec; 6():39119. PubMed ID: 27991598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]